Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

blank

 

Recent News and Articles on the Keywords: dansk droge + orkla + acquisition  Related to the article below (Last Update: 7/1/2008)

Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density … -
H Pedersen, M Petersen, A Major-Pedersen, T Jensen … - European Journal of Clinical Nutrition, 2003 - nature.com
... Sponsorship: Financially supported by The Danish Heart Association and Dansk Droge
A/S. Dansk Droge A/S generously provided the fish oil and corn oil capsules. ...

Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial … -
B Turner, C Molgaard, P Marckmann - British Journal of Nutrition, 2004 - pt.wkhealth.com
... 1 Dansk Droge, Industrigrenen 10, DK-2635 Ish?j, Denmark. ... We thank Dansk Droge, Ish?j,
Denmark, for sponsoring the present study. References TOP. ...

Gerimax Ginseng Regulates Both Humoral and Cellular Immunity During Chronic Pseudomonas aeruginosa … -
Z Song, H Wu, K Mathee, N Hoiby, A Kharazmi - The Journal of Alternative & Complementary Medicine, 2002 - liebertonline.com
... Objective: In this study we compared the therapeutical effect of Gerimax (Dansk
Droge A/S, Ish?j, Denmark) ginseng with placebo control by using a rat model ...

[CITATION] Ginseng modulates the immune response by induction of interleukin-12 production -
MW LARSEN, C MOSER, N HOIBY, Z SONG, A KHARAZMI - Apmis, 2004 - Blackwell Synergy
... Gerimax Ginseng Extract (GGE), which is dried Panax ginseng CA Meyer extract,
was obtained from Dansk Droge A/S (Ish?j, Denmark). ...

Postpartum Thyroid Dysfunction in Pregnant Thyroid Peroxidase Antibody-Positive Women Living in an … -
SB Nohr, A Jorgensen, KM Pedersen, P Laurberg - Journal of Clinical Endocrinology & Metabolism, 2000 - Endocrine Soc
... The vitamin tablets (Livol Super) were provided by Dansk Droge A/S (Copenhagen,
Denmark) and contained the recommended daily allowances of various vitamins and ...

Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial -
R Christensen, A Astrup, H Bliddal - Osteoarthritis and Cartilage, 2005 - Elsevier
... The LED consisted of nutrition powder (Speasy ? , Dansk Droge A/S) dissolved in
water and was taken as six daily meals, giving the patient 3.4 MJ/day. ...

Effect of dried garlic powder tablets on postprandial increase in pulse wave velocity after a fatty … -
B Turner, C M?lgaard, P Marckmann - Scandinavian Journal of Food & Nutrition, 2005 - informaworld.com
... Centre for Advanced Food Studies, The Royal Veterinary and Agricultural University,
Frederiksberg, Denmark; Present affiliations: 1 Dansk Droge, Ish?j, Denmark ...

LOW-ENERGY-DIET -
A ASTRUP, S TOUBRO - EP Patent 1,534,087, 2005 - freepatentsonline.com
... Export Citation: Click for automatic bibliography generation. Assignee: DANSK
DROGE AS (DK). International Classes: A23L1/307. Priority ...
-

[CITATION] SUSTAINED WEIGHT LOSS AS TREATMENT OF KNEE OSTEOARTHRITIS IN OBESE PATIENTS: LONG-TERM RESULTS FROM …
R Christensen, A Astrup, H Bliddal - ardmtg, 2005 - BMJ Publishing Group Ltd

[PPT] Speaker background
C FINANCE - isis.ku.dk
... Sep 06. Undisclosed. Advisor to Polaris and the M?ller Hansen family in connection
with the sale of Dansk Droge. Dansk Droge. Sep 06. DKK 2bn. ...
-

Source: Google Scholar
 
 

Orkla bids on health with Dansk Droge acquisition

Norway’s Orkla has snapped up all shares in Danish supplement-maker Dansk Droge, as it positions to take advantage of consumer health trends.

 
Since 2002 Polaris private equity has held 72 per cent of shares in Dansk Droge, whose health brands include Litozin, Futura, Gerimax and Livol. Dansk Droge reported operating revenue of NOK 400m (c €51m) in 2005.

Around 17 per cent of this revenue was generated by sports nutrition companies SPP in Sweden and Finland, which are excluded from the transaction.

The value of the transaction has not been revealed.

Orkla, a supplier of branded consumer goods, has been in a strong position to make acquisitions, reporting a 75 per cent increase in operating profit in 2005 over 2004, to NOK4805m (€614m).

But although Orkla Brands' operating profit before amortisation rose ten per cent to NOK1049m (€134m), dietary supplements and health products achieved profit growth as one of the only two units to actually achieve profit growth. The operating profit increase was attributed to expansion.

The supplements business consists of Peter Möller and Collett Pharma, the latter acquired last year and considered to be “important element of efforts to establish a Nordic position in the dietary supplements and health product category.” The two have now been merged under the name MöllerCollett and integration work is ongoing.

Polaris managing director Viggo nedergaard Jensen said: “In Orkla, Dansk Droge has a new owner with a strong position as a supplier of branded consumer goods to Nordic retailers.”

Dansk Droge has also been busy expanding its export sales in recent years. Exports to more than 25 countries account for around 60 per cent of operating revenues.

 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page